Cargando…
Sequential combination of cisplatin with eugenol targets ovarian cancer stem cells through the Notch-Hes1 signalling pathway
BACKGROUND: Ovarian carcinomas are the deadliest gynecological malignancies owing to their high rate of recurrence and high resistance to platinum-based chemotherapy. Recent studies have shown platinum-dependent enrichment of ovarian tumors with side population as well as cancer stem cells, which ar...
Autores principales: | Islam, Syed S., Aboussekhra, Abdelilah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716935/ https://www.ncbi.nlm.nih.gov/pubmed/31470883 http://dx.doi.org/10.1186/s13046-019-1360-3 |
Ejemplares similares
-
Eugenol triggers apoptosis in breast cancer cells through E2F1/survivin down-regulation
por: Al-Sharif, Ibtehaj, et al.
Publicado: (2013) -
Activated breast stromal fibroblasts exhibit myoepithelial and mammary stem cells features
por: Aboussekhra, Abdelilah, et al.
Publicado: (2023) -
Genetic alterations of Keap1 confers chemotherapeutic resistance through functional activation of Nrf2 and Notch pathway in head and neck squamous cell carcinoma
por: Islam, Syed S., et al.
Publicado: (2022) -
Hes1 regulates embryonic stem cell differentiation by suppressing Notch signaling
por: Kobayashi, Taeko, et al.
Publicado: (2010) -
Hes repressors are essential regulators of hematopoietic stem cell development downstream of Notch signaling
por: Guiu, Jordi, et al.
Publicado: (2013)